Silver Book Fact

Between August 2004 and July 2014, the FDA approved:

  • Six new anticancer therapeutics
  • Five new uses for previously approved anticancer therapeutics
  • Two new uses for imaging agents
  • One new use for a screening test

AACR Cancer Progress Report 2014. Clin Cancer Res Web site. http://clincancerres.aacrjournals.org/content/20/19/4977.full. Published 2014

Reference

Title
AACR Cancer Progress Report 2014
Publication
Clin Cancer Res
Publication Date
Published 2014
Authors
American Association for Cancer Research
Volume & Issue
Volume 20, Issue S1
Pages
S1-S112
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • Medicines in Development for Cancer  
  • Improvement in 5-Year Survival Rates for All Cancers Since 1975
     
  • In 1971, one in 69 people was a cancer survivor (three million survivors). In 2014, that number grew to one in 22 people (14.5 million survivors).  
  • A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.